Company intelligence / Profile preview

Clear Street

New York City, New York, United Statesclearstreet.io ↗

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Clear Street is a cloud-native financial technology firm modernizing brokerage infrastructure for institutional clients. In late 2024, it launched an equity research franchise focused on healthcare and biotechnology, providing in-depth market analysis and investment insights to institutional investors. The team covers multiple therapeutic areas including oncology, autoimmune diseases, ophthalmology, genetic medicine, cell therapy, gene therapy, and RNA technologies. However, Clear Street itself does not conduct clinical trials or have its own drug pipeline.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships reported; partnerships are primarily with institutional clients in finance.

Beyond the preview

Go deeper on Clear Street.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clear Street.

Explore the full profile